Development and Validation of a Risk-Prediction Nomogram for Preoperative Blood Type and Antibody Testing in Spinal Fusion Surgery

Linghong Wu, Xiaozhong Peng, Xianglong Zhuo, Guangwei Zhu, Xiangtao Xie

PDF
Orthopaedic Surgery ›› 2024, Vol. 16 ›› Issue (1) : 111-122. DOI: 10.1111/os.13946
CLINICAL ARTICLE

Development and Validation of a Risk-Prediction Nomogram for Preoperative Blood Type and Antibody Testing in Spinal Fusion Surgery

Author information +
History +

Abstract

Objective:: With advancements in minimally invasive techniques, the use of spinal fusion surgery is rapidly increasing and transfusion rates are decreasing. Routine preoperative ABO/Rh blood type and antibody screening (T&S) laboratory tests may not be appropriate for all spinal fusion patients. Herein, we constructed a nomogram to assess patient transfusion risk based on various risk factors in patients undergoing spinal fusion surgery, so that preoperative T&S testing can be selectively scheduled in appropriate patients to reduce healthcare and patient costs.

Methods:: Patients who underwent spinal fusion surgery between 01/2020 and 03/2023 were retrospectively examined and classified into the training (n = 3533, 70%) and validation (n = 1515, 30%) datasets. LASSO and multivariable logistic regression were used to analyze risk factors for blood transfusion. Nomogram predictive model was built according to the independent predictors and mode predictive power was validated using consistency index (C-index), Hosmer–Lemeshow (HL) test, calibration curve analysis and area under the curve (AUC) for receiver operating characteristic (ROC) curve. Bootstrap resampling was used for internal validation. Decision curve analysis (DCA) was applied to evaluate the model's performance in the clinic.

Results:: Being female, age, BMI, admission route, critical patient, operative time, heart failure, end-stage renal disease or chronic kidney disease (ESRD or CKD), anemia, and coagulation defect were predictors of blood transfusion for spinal fusion. A prediction nomogram was developed according to a multivariate model with good discriminatory power (C-index = 0.887); Bootstrap resampling internal validation C-index was 0.883. Calibration curves showed strong matching between the predicted and actual probabilities of the training and validation sets. HL tests for the training and validation sets had p-values of 0.327 and 0.179, respectively, indicating good calibration. When applied to the training set, the following parameters were found: AUC: 0.895, 95% CI: 0.871–0.919, sensitivity 78.2%, specificity 86.7%, positive predictive value 29.4% and negative predictive value 98.2%. If the model were applied in the training set, 2911 T&S tests (82.4%) would be eliminated, equaling a RMB349,320 cost reduction. The AUC in the internal validation was: 0.879, 95% CI: 0.839–0.927, sensitivity 75.2%, specificity 88.8%, positive predictive value 34.3%, negative predictive value 97.9%, would eliminate 1276 T&S tests (84.2%), saving RMB 153,120. The DCA curve indicated good clinical application value.

Conclusion:: The nomogram based on 10 independent factors can help healthcare professionals predict the risk of transfusion for patients undergoing spinal fusion surgery to target preoperative T&S testing to appropriate patients and reduce healthcare costs.

Keywords

ABO/Rh Type / Antibody Screening / Nomogram / Spinal Fusion Surgery / Transfusion

Cite this article

Download citation ▾
Linghong Wu, Xiaozhong Peng, Xianglong Zhuo, Guangwei Zhu, Xiangtao Xie. Development and Validation of a Risk-Prediction Nomogram for Preoperative Blood Type and Antibody Testing in Spinal Fusion Surgery. Orthopaedic Surgery, 2024, 16(1): 111‒122 https://doi.org/10.1111/os.13946

References

[1]
Peng L, Guo J, Lu JP, Jin S, Wang P, Shen HY. Risk factors and scoring system of cage retropulsion after posterior lumbar interbody fusion: a retrospective observational study. Orthop Surg. 2021;13:855–862.
[2]
Lopez CD, Boddapati V, Lombardi JM, Lee NJ, Saifi C, Dyrszka MD, et al. Recent trends in medicare utilization and reimbursement for lumbar spine fusion and discectomy procedures. Spine J. 2020;20:1586–1594.
[3]
Paynter JW, Raley JA, Kyrkos JG, Paré DW, Houston H, Crosby LA, et al. Routine postoperative laboratory tests are unnecessary after primary reverse shoulder arthroplasty. J Shoulder Elbow Surg. 2020;29:1656–1664.
[4]
Torres-Ruiz MF, Aguirre-Olmedo I, del Carmen T-GM, et al. Routine preoperative tests in low-risk surgery. What about adherence to clinical guidelines? Med Res Arch. 2023;11:1–10.
[5]
Mutter O, Taylor GA, Grebenyuk E, Kuo LE, Sanserino KA. Utility of routine preoperative laboratory testing for low-risk patients in ambulatory gynecologic surgery. J Minim Invasive Gynecol. 2021;28:1033–1040.e1.
[6]
Metz AK, Berlin NL, Yost ML, Cheng B, Kerr E, Nathan H, et al. Comprehensive history and physicals are common before low-risk surgery and associated with preoperative test overuse. J Surg Res. 2023;283:93–101.
[7]
Keay L, Lindsley K, Tielsch J, Katz J, Schein O. Routine preoperative medical testing for cataract surgery. Cochrane Database Syst Rev. 2019;1:CD007293.
[8]
Kling S, Taylor G, Philp M, Poggio J, Ross H, Kuo L. Use of preoperative laboratory testing among low-risk patients undergoing elective anorectal surgery. J Surg Res. 2022;270:421–429.
[9]
Ondeck N, Fu M, McLynn R, Bovonratwet P, Malpani R, Grauer J. Preoperative laboratory testing for total hip arthroplasty: unnecessary tests or a helpful prognosticator. J Orthop Sci. 2020;25:854–860.
[10]
Siddaiah H, Patil S, Shelvan A, Ehrhardt KP, Stark CW, Ulicny K, et al. Preoperative laboratory testing: implications of "choosing wisely" guidelines. Best Pract Res Clin Anaesthesiol. 2020;34:303–314.
[11]
Dossett LA, Edelman AL, Wilkinson G, Ruzycki SM. Reducing unnecessary preoperative testing. BMJ. 2022;379:e070118.
[12]
Clark K, Luhmann S. Utility of preoperative labs in posterior spinal fusions for idiopathic scoliosis. Spine Deform. 2021;9:1379–1385.
[13]
Baird G. The choosing wisely initiative and laboratory test stewardship. Diagnosis. 2019;6:15–23.
[14]
Zhou ZK, Huang ZY, Yang HL, et al. Expert consensus on the application of tranexamic acid and anticoagulant for the enhanced recovery after orthopedic surgery in China. Chin J Bone Jt Surg. 2019;12:81–88.
[15]
Terada R, Stewart K, Hansen S, Shettar SS, Butt A, Vallurupalli S, et al. Temporal changes and predictors of perioperative blood transfusion in elective spine surgery: a retrospective analysis of a large surgical database. Br J Anaesth. 2023;130:421–429.
[16]
Krishna HM, Prasad MK, Mitragotri MV, Bipin GI, Gupta D, Sharma R. Recent advances in perioperative blood management. Indian J Anaesth. 2023;67:130–138.
[17]
Barrie U, Youssef CA, Pernik MN, Adeyemo E, Aoun SG. Transfusion guidelines in adult spine surgery: a systematic review and critical summary of currently available evidence. Spine J. 2021;1:1–28.
[18]
Carson JL, Guyatt G, Heddle NM, Grossman BJ, Tobian AAR. Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA. 2016;316:2025–2035.
[19]
Turcotte J, Holbert S, Orlov M, Patton C. Development and validation of a risk-based algorithm for preoperative type and screen testing in spine surgery. Spine J. 2022;22:1472–1480.
[20]
Vora A, Stanislawski M, Grunwald G, et al. Association between chronic kidney disease and rates of transfusion and progression to end-stage renal disease in patients undergoing transradial versus transfemoral cardiac catheterization-an analysis from the veterans affairs clinical assessment reporting and tracking (CART) program. J Am Heart Assoc. 2017;6:e004819.
[21]
Cappell K, Shreay S, Cao Z, Varker H, Paoli C, Gitlin M. Red blood cell (RBC) transfusion rates among US chronic dialysis patients during changes to Medicare end-stage renal disease (ESRD) reimbursement systems and erythropoiesis stimulating agent (ESA) labels. BMC Nephrol. 2014;15:116–126.
[22]
Abdelmaguid A, Roberts LN, Tugores L, Joslin JR, Hunt BJ, Parmar K, et al. Evaluation of novel coagulation and platelet function assays in patients with chronic kidney disease. J Thromb Haemost. 2022;20:845–856.
[23]
Ocak G, Ramspek C, Rookmaaker M, et al. Performance of bleeding risk scores in dialysis patients. Nephrol Dial Transplant. 2019;34:1223–1231.
[24]
van Eck van der Sluijs A, Abrahams A, Rookmaaker M, et al. Bleeding risk of haemodialysis and peritoneal dialysis patients. Nephrol Dial Transplant. 2021;36:170–175.
[25]
Madsen C, Jørgensen H, Norgaard A, et al. Preoperative factors associated with red blood cell transfusion in hip fracture patients. Arch Orthop Trauma Surg. 2014;134:375–382.
[26]
Stammers A, Tesdahl E, Mongero L, Stasko A. Gender and intraoperative blood transfusion: analysis of 54,122 non-reoperative coronary revascularization procedures. Perfusion. 2019;34:236–245.
[27]
Song K, Pan P, Yao Y, Jiang T, Jiang Q. The incidence and risk factors for allogenic blood transfusion in total knee and hip arthroplasty. J Orthop Surg Res. 2019;14:273–278.
[28]
Unal D, Senayli Y, Polat R, Spahn DR, Toraman F, Alkis N, et al. Peri-operative blood transfusion in elective major surgery: incidence, indications and outcome–an observational multicentre study. Blood Transfus. 2020;18:261–279.
[29]
Duncan S, Sperling J, Morrey B. Incidence and risk factors for blood transfusion in total elbow arthroplasty. J Shoulder Elbow Surg. 2008;17:961–962.
[30]
Ahmadi S, Lawrence T, Sahota S, et al. The incidence and risk factors for blood transfusion in revision shoulder arthroplasty: our institution's experience and review of the literature. J Shoulder Elbow Surg. 2014;23:43–48.
[31]
Liu B, Pan J, Zong H, Wang Z. Establishment and verification of a perioperative blood transfusion model after posterior lumbar interbody fusion: a retrospective study based on data from a local hospital. Front Surg. 2021;8:347–355.
[32]
Stojadinovic IB, Ristic BM, Knezevic DR, Milenkovic ZS, Prodanovic NS, Zornic NR, et al. The effect of tranexamic acid on the reduction of intraoperative and postoperative blood loss and thromboembolic risk in patients with hip fracture. Open Med. 2022;17:857–862.
[33]
Legnani C, Oriani G, Parente F, Ventura A. Reducing transfusion requirements following total knee arthroplasty: effectiveness of a double infusion of tranexamic acid. Eur Rev Med Pharmacol Sci. 2019;23:2253–2256.
[34]
Goyal A, Ngufor C, Kerezoudis P, Mccutcheon B, Bydon M. Can machine learning algorithms accurately predict discharge to nonhome facility and early unplanned readmissions following spinal fusion? Analysis of a national surgical registry. J Neurosurg Spine. 2019;31:1–11.

RIGHTS & PERMISSIONS

2023 2023 The Authors. Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.
PDF

Accesses

Citations

Detail

Sections
Recommended

/